However, further research strategies for targeting Csnk1a1 to treat glioblastoma should address the roles of TP 53 and NF‐κB signalling pathways in the regulation of inflammatory cytokine secretion by glioma cells. The gene discussed is NFKB1; the disease is central nervous system cancer.